David Hession - 02 Mar 2022 Form 4 Insider Report for Dorman Products, Inc. (DORM)

Role
SVP and CFO
Signature
/s/ Frank J. Mahr, by Power of Attorney
Issuer symbol
DORM
Transactions as of
02 Mar 2022
Net transactions value
-$18,308
Form type
4
Filing time
04 Mar 2022, 14:29:41 UTC
Previous filing
03 Mar 2022
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DORM Common Stock Tax liability $18,308 -190 -3.2% $96.36 5,657 02 Mar 2022 Direct F1
transaction DORM Common Stock Award $0 +943 +17% $0.000000 6,600 02 Mar 2022 Direct F2
transaction DORM Common Stock Award $0 +2,594 +39% $0.000000 9,194 02 Mar 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DORM Employee Stock Option (right to buy) Award $0 +2,811 $0.000000 2,811 02 Mar 2022 Common Stock 2,811 $96.36 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
F2 Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in four equal annual installments beginning on March 2, 2023, which is the first anniversary of the date of grant.
F3 Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on March 2, 2025, the third anniversary of the date of grant.
F4 The option vests in four equal annual installments beginning on March 2, 2023, which is the first anniversary of the date of grant.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.